Skip to main content

Table 2 Multivariable linear regression evaluating biomarkers linking to muscle strength, muscle mass, fat mass and bone mass adjusted for age

From: Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women

Handgrip (right)

R2

beta

95%CI

P value

 DHEA

0.611

0.403

0.352 ~ 0.454

0.041

 T2

0.005

−1.224

−4.6854-2.236

0.484

 E2

0.002

−0.013

− 0.078-0.051

0.682

Gait speed

 

beta

95%CI

P value

 DHEA

0.234

0.58

0.576 ~ 0.587

0.004

 T2

0.006

−1.198

−4.389-1.993

0.458

 E2

0.002

0.013

−0.046-0.073

0.657

Lean mass

 

beta

95%CI

P value

 Follistatin

0.365

−0.28

−0.309 ~ − 0.243

0.010

 Oxytocin

0.272

0.35

0.306 ~ 0.398

0.036

Fat mass

 

beta

95%CI

P value

 Myostatin

0.362

0.92

0.881 ~ 0.960

0.021

ASMI

 

beta

95%CI

P value

 Myostatin

0.356

−0.31

−0.352 ~ −0.251

0.032

 Follistatin

0.227

−0.48

−0.529 ~ − 0.430

0.042

BMD (lumbar spine)

 

beta

95%CI

P value

 CTX

0.572

−0.42

−0.420 ~ − 0.412

< 0.001

 DHEA

0.415

0.38

0.338 ~ 0.414

0.022

 T2

0.003

0.025

−0.065-0.114

0.586

 E2

0.027

0.001

0.000–0.003

0.123

BMD (femur neck)

 

beta

95%CI

P value

 Oxytocin

0.347

0.61

0.576 ~ 0.642

0.014

BMD (total hip)

 

beta

95%CI

P value

 DHEA

0.285

0.52

0.480 ~ 0.551

0.017

 T2

0.005

0.031

−0.065-0.127

0.521

 E2

0.002

0.001

−0.002-0.001

0.665

 Oxytocin

0.366

0.59

0.535–0.651

0.044

  1. R2 coefficient of determination, Beta standardized regression coefficients, P-value significant level at p < 0.05. DHEA Dehydroepiandrosterone, E2 Estradiol, T2 Testosterone, ASMI Appendicular skeletal mass index, BMD Bone mineral density, CTX C-telopeptide collagen crosslinks